Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Prostate Cancer
100%
Partial Nephrectomy
59%
Kidney Tumour
43%
Biopsy Technique
40%
Prostatectomy
39%
Bladder
33%
Neoplasm
31%
Diseases
30%
Prostate Specific Antigen
29%
Clear Cell Renal Cell Carcinoma
27%
Lower Urinary Tract Symptom
27%
Cystectomy
26%
Chronic Pelvic Pain Syndrome
25%
Urinary System
23%
Surgeon
22%
Malignant Neoplasm
21%
Tumor
21%
Prostate Biopsy
20%
Dutasteride
16%
Recurrent Disease
16%
Transitional Cell Carcinoma
15%
Pelvis
15%
Nephrectomy
14%
Cancer
14%
Radical Nephrectomy
13%
Magnetic Resonance Imaging
13%
Arm
13%
Bladder Cancer
13%
Pelvis Pain Syndrome
13%
Prostate Hypertrophy
13%
Morbidity
13%
Interstitial Cystitis
13%
Kidney Stone
12%
Bleeding
12%
Cystalgia
12%
Systematic Review
12%
Quality of Life
12%
Ureteroscopy
12%
Overall Survival
12%
Odds Ratio
11%
Pain
11%
Pediatrics
11%
Ovarian Cancer Screening
11%
Lung Cancer Screening
10%
Laparoscopic Surgery
10%
Colorectal Cancer Screening
10%
Ureter
10%
Urologist
9%
Urine Incontinence
9%
Retroperitoneal Lymph Node Dissection
9%
Kidney Cancer
9%
Body Mass Index
9%
Placebo
9%
Incontinence
9%
Enuresis
9%
Urinary Tract Infection
9%
Gleason Score
9%
Health Care Cost
9%
Cryoablation
9%
Cryosurgery
9%
Non Muscle Invasive Bladder Cancer
9%
Kidney Function
9%
Cancer Screening
8%
Clinical Trial
8%
Urology
8%
Surgical Technique
8%
Kidney Surgery
8%
Nephroureterectomy
8%
Stress Incontinence
8%
Radiation Therapy
7%
Chemotherapy
7%
Minimally Invasive Procedure
7%
Percutaneous Nephrolithotomy
7%
Ischemia
7%
Robot-Assisted Prostatectomy
7%
Pyeloplasty
7%
Surgery
7%
Postoperative Complication
7%
Pelvic Pain
7%
Robot-Assisted Surgery
6%
Comorbidity
6%
Urinary Diversion
6%
Logistic Regression Analysis
6%
Surgical Margin
6%
Cancer Mortality
6%
Biological Marker
6%
Hydronephrosis
6%
Meta-Analysis
6%
Infection
6%
Incision
6%
Peroperative Complication
5%
Learning Curve
5%
Holmium
5%
Digital Rectal Examination
5%
Obstruction
5%
Artificial Urinary Sphincter
5%
Hazard Ratio
5%
Injection
5%
Treatment Option
5%
Lung
5%
Keyphrases
Prostate Cancer
82%
Prostate Cancer Risk
24%
Lower Urinary Tract Symptoms
23%
Prostate Cancer Screening
22%
Dutasteride
20%
Prostate-specific Antigen
19%
Radical Prostatectomy
18%
Prostate
17%
Renal Cell Carcinoma
17%
Urologic Chronic Pelvic Pain Syndrome
16%
Tumor
16%
Radical Cystectomy
16%
Bladder
15%
Renal Mass
14%
Benign Prostatic Hyperplasia
14%
Robot-assisted Partial Nephrectomy
12%
95% Confidence Interval
12%
Small Renal Mass
12%
Odds Ratio
12%
Partial Nephrectomy
11%
Active Surveillance
11%
Non-muscle Invasive Bladder Cancer (NMIBC)
11%
Prostate Biopsy
11%
Robotic Partial Nephrectomy
11%
Oncological Outcomes
10%
Bladder Cancer
10%
Laparoscopic Partial Nephrectomy
10%
Overactive Bladder
10%
Interstitial Cystitis/bladder Pain Syndrome
10%
Surgeons
10%
Postoperative Outcomes
10%
Laparoscopic Nephrectomy
10%
Chronic Pelvic Pain
9%
Kidney
9%
ACK1
9%
Robot-assisted Radical Cystectomy
9%
Overall Survival
9%
Network Studies
9%
Ovarian Cancer Screening
8%
Colorectal Cancer Screening
8%
Lung Cancer Screening
8%
Upper Tract Urothelial Carcinoma
8%
Multidisciplinary Approach
8%
Renal Tumor
8%
Operative Time
8%
Ureter
7%
Urinary Symptoms
7%
Multi-institutional
7%
Urologists
7%
Robotics
7%
Total Prostate-specific Antigen
6%
Multivariable
6%
Multiparametric Magnetic Resonance Imaging (mpMRI)
6%
Ureteroscopy
6%
Prostate-specific Antigen Level
6%
Urinary Tract Infection
6%
Placebo
6%
Genome-wide Association Study
6%
Radical Nephrectomy
6%
Aggressive Prostate Cancer
5%
Quality of Life
5%
Androgen Receptor
5%
Urologic
5%
High-grade Prostate Cancer
5%
Digital Rectal Examination
5%
Hazard Ratio
5%
Prostate Volume
5%
Prostate-specific Antigen Testing
5%
Finasteride
5%
Patient Selection
5%
Cardiac Magnetic Resonance Imaging (cMRI)
5%
Percutaneous Nephrolithotomy
5%
Body Mass Index
5%
Non-associated
5%
Lung
5%
Tumor Size
5%
Randomized Trial
5%
Learning Curve
5%
Urinary Urgency
5%
Single nucleotide Polymorphism
5%